Amsterdam Cardiovascular Sciences

Intermediate Effect Variants in HCM: Integration into Clinical Practice and Family Screening

Walsh, R., Garcia-Pavia, P. & Ochoa, J. P., 5 May 2026, In: Circulation. 153, 18, p. 1347-1349 3 p.

Research output: Contribution to Journal › Article › Academic › peer-review

Titin and the mystery of cardiomyopathy incidence

Jurgens, S. J. & Walsh, R., 21 Dec 2025, In: European Heart journal. 46, 48, p. 5258-5260

Research output: Contribution to Journal › Editorial › Academic › peer-review

Redefining the Genetic Architecture of Hypertrophic Cardiomyopathy: Role of Intermediate-Effect Variants

García Hernandez, S., de la Higuera Romero, L., Fernandez, A., Luisa Peña Peña, M., Mora-Ayestaran, N., Basurte-Elorz, M. T., Larrañaga-Moreira, J. M., Cárdenas Reyes, I., Villacorta, E., Valverde-Gómez, M., Baustista-Paves, A., Veira Villanueva, E., Ortiz-Genga, M., Lipov, A., Brogger, N., Sabater Molina, M., Moreno-Escobar, E., Ruiz-Guerrero, L., Syrris, P. & Fernández, X. & 9 others, Piqueras-Flores, J., Amor Salamanca, A., Bezzina, C. R., Elliott, P. M., Barriales-Villa, R., Gimeno-Blanes, J. R., García-Pavía, P., Walsh, R. & Ochoa, J. P., 14 Oct 2025, In: Circulation. 152, 15, p. 1060-1075 16 p.

Research output: Contribution to Journal › Article › Academic › peer-review